Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
BTIG analyst Julian Harrison downgraded Outlook Therapeutics Inc (NASDAQ:OTLK) from Buy to Neutral. Outlook Therapeutics shares closed at $0.23 on Friday. See how other analysts view this stock.
Morgan Stanley analyst Shane Brett downgraded Applied Materials Inc (NASDAQ:AMAT) from Overweight to Equal-Weight and announced a $502 price target. Applied Materials shares closed at $436.62 on Friday. See how other analysts view this stock.
DA Davidson analyst Gil Luria downgraded CoreWeave Inc (NASDAQ:CRWV) from Buy to Neutral and cut the price target from $175 to $100. CoreWeave shares closed at $107.30 on Friday. See how other analysts view this stock.
Leerink Partners analyst Andrew Berens downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) from Outperform to Market Perform and slashed the price target from $792 to $641. Regeneron Pharmaceuticals shares closed at $698.25 on Friday. See how other analysts view this stock.
